Management and Outcomes of HIV-Associated Primary Effusion Lymphoma: A Single Center Experience

Arjun Gupta, Shiraj Sen, Eileen Marley, Weina Chen, Harris V. Naina

Research output: Contribution to journalArticle

8 Scopus citations


Micro-Abstract Primary effusion lymphoma (PEL) is a rare form of lymphoma, primarily seen in individuals who are immunosuppressed. We studied all cases of PEL seen at our institution over a 15-year period and observed that if affected mostly male patients with HIV who were not taking the antiretroviral medication. Newer chemotherapy regimens including the drug bortezomib may be more effective in treating PEL.

Original languageEnglish (US)
Pages (from-to)S175-S180
JournalClinical Lymphoma, Myeloma and Leukemia
StatePublished - Aug 1 2016



  • Bortezomib
  • Epidemiology
  • Kaposi sarcoma-associated herpesvirus
  • Management
  • Outcomes
  • Primary effusion lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this